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We report a role for Nogo receptors (NgRs) in
macrophage efflux from sites of inflammation
in peripheral nerve. Increasing numbers ofmac-
rophages in crushed rat sciatic nerves express
NgR1 and NgR2 on the cell surface in the first
week after injury. These macrophages show re-
duced binding to myelin and MAG in vitro,
which is reversed by NgR siRNA knockdown
and by inhibiting Rho-associated kinase. Four-
teen days after sciatic nerve crush, regenerat-
ing nerves with newly synthesized myelin have
fewer macrophages than cut/ligated nerves
that lack axons and myelin. Almost all macro-
phages in the cut/ligated nerves lie within the
Schwann cell basal lamina, while in the crushed
regenerating nerves the majority migrate out.
Furthermore, crush-injured nerves of NgR1-
and MAG-deficient mice and Y-27632-treated
rats show impaired macrophage efflux from
Schwann cell basal lamina containing myelin-
ated axons. These data have implications for
the resolution of inflammation in peripheral
nerve and CNS pathologies.
INTRODUCTION
Macrophages respond rapidly to injury and other insults to
the nervous system and play an important role in tissue re-
pair. Successful repair also requires that these cells be
signaled to leave the site of injury appropriately and thus
prevent chronic inflammation. Macrophages, primarily of
hematogenous origin, are recruited into the degenerating
distal segment of the injured nerve between 2 and 3 days
after injury (Bendszus and Stoll, 2003; Bruck, 1997; Muel-
ler et al., 2003; Perry et al., 1987) and increase in number in
the first 2 weeks. The initial breakdown of the axon itself
occurs rapidly within the first day, undergoing granular de-
generation of cytoskeletal structures via the action of cal-
cium-dependent endogenous proteolytic activity and
does not require the presence of macrophages (Colemanand Perry, 2002; George et al., 1995). Macrophages
phagocytose axonal and myelin debris particularly in the
first 2 weeks and decrease in number thereafter (Bend-
szus and Stoll, 2003; Mueller et al., 2003). The factors
that regulate the recruitment and activation of macro-
phages during Wallerian degeneration have been inten-
sively studied (De et al., 2003; Rotshenker, 2001; Stoll
and Jander, 1999). However, little is known of the mecha-
nisms that signal the clearance or elimination of macro-
phages from the nerve at the end of the period ofWallerian
degeneration. Apoptosis has been reported to account for
the loss of only a very small number of macrophages
(Kuhlmann et al., 2001; Mueller et al., 2003). The available
evidence suggests that the majority of these macro-
phages leave the nerve via the circulation to the spleen
and draining lymph nodes (Kuhlmann et al., 2001). The sig-
nals that trigger the end-stage phagocytic macrophages
to migrate out of the nerve are still not known.
Weshowhere thatmacrophageclearance from lesioned
peripheral nerves is mediated in part by Nogo receptors
(NgRs). Three members of the NgR family, NgR1, NgR2,
and NgR3, have recently been identified (Venkatesh
et al., 2005). Of these, NgR1 has been extensively studied
in neurons and shown to induce repulsive effects on the
growth cone leading to its collapse, and possibly to inhibi-
tion of axon regeneration (Filbin, 2003; Fournier and Stritt-
matter, 2001; McKerracher and David, 2004). NgR1 binds
to three axon growth inhibitory molecules in myelin: Nogo-
A, myelin-associated glycoprotein (MAG), and oligoden-
drocyte-myelin glycoprotein (OMgp), while NgR2 binds
selectively to MAG but not Nogo-A and OMgp (Filbin,
2003; Venkatesh et al., 2005). We now provide evidence
that NgR1 and NgR2 are expressed on the surface of
phagocytic macrophages and that interaction between
these receptors and their ligandssuchasMAG, associated
with newly synthesized myelin wrapping around regener-
ated axons, mediates the efflux of macrophages out of
the Schwann cell basal lamina. The efflux of macrophages
into the endoneurial space appears to be an important first
step in their eventual migration out of the injured nerve, re-
sulting in the resolution of the inflammatory response after
peripheral nerve injury.Our current studies therefore reveal
a novel role (to our knowledge) for NgRs in the immune cell
response in injured peripheral nerves and may also have
implications for other nervous system pathologies.Neuron 53, 649–662, March 1, 2007 ª2007 Elsevier Inc. 649
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NgR Mediates Macrophage Repulsion in Injured NerveFigure 1. NgR1 Expression Is Lost in
Axons after Crush Injury
Double immunofluorescence labeling of NgR1
(A) and neurofilament (B) in a longitudinal sec-
tion of uninjured rat sciatic nerve shows coloc-
alization of NgR1 in axons ([A–C], arrows). At 3
days after crush injury, NgR1 expression is not
seen in degenerating axons (D–F) but is ob-
served in a few cells containing neurofilament
debris (arrows in [D] and [F]). These NgR1+ cells
increase in number at 5 days post-injury ([G–I],
arrows), but the newly regenerated neurofila-
ment+ axons do not express NgR1 (I). Luxol
fast blue staining for myelin (K) of 5 day post-
crush nerve shows that NgR1+ cells contain
myelin debris ([J–L], arrows), indicating that
these cells are macrophages. Micrographs
are of longitudinal sections of injured nerve,
2mmdistal to the crush site. Scale bar, 100 mm.RESULTS
Loss of NgR1 Expression in Degenerating Axons
Robust expression of NgR1 is detected in intact axons of
the normal adult rat sciatic nerve (Figures 1A–1C). The ax-
onal labeling with the anti-NgR1 antibody was confirmed
by its colocalization with profiles containing neurofilament
(Figure 1C). Within 3 days after a sciatic nerve crush injury
in adult rats, all the axons degenerate. This is evident from
the lack of neurofilament immunoreactivity (Figure 1E) and
is in keeping with previous reports of rapid calcium-
dependent degeneration of axons that does not require the
presence of macrophages (George et al., 1995). The label-
ing with the anti-neurofilament antibody is confined to
small globular structures that are likely to be the remnants
of degenerated neurofilaments (Figure 1E). The NgR1 im-
munoreactivity that is normally associated with axons is
therefore completely lost at 3 days post-crush injury (Fig-
ures 1D and 1F). The loss of neurofilament and NgR1 is not
due to phagocytosis by macrophages because at 3 days
post-injury they are in the initial stages of recruitment,
and there are only a fewmacrophages in the degenerating
nerve (Bruck, 1997; Mueller et al., 2003).
NgR Expression in Macrophages
in the Degenerating Nerve
Regenerating axons are present in the distal nerve seg-
ment by 5 days after crush injury, but these axons do
not express NgR1 (Figures 1G–1I). This immunoreactivity
returns several weeks later when the axons have reinner-
vated their targets (data not shown). However, a small
number of NgR1+ cells appear in the degenerating nerve
at day 3 (Figure 1D) and increase in number thereafter
(Figure 1G). At 3 days, these NgR1+ cells contain neurofi-650 Neuron 53, 649–662, March 1, 2007 ª2007 Elsevier Inc.lament debris (Figure 1F), but this is not evident at day 5
(Figure 1I). Furthermore, double labeling tissue sections
with Luxol fast blue, a histological stain for myelin, reveals
that the NgR1+ cells colocalize with degenerating myelin
ovoids (Figures 1J–1L), suggesting that they may be mac-
rophages that have phagocytosed myelin debris. Addi-
tional evidence that these NgR1+ cells are also OX-42+
confirm that they are macrophages (Figures 2A–2F). Mac-
rophages in the degenerating crush-injured nerves almost
double in number between days 3 and 5 post-injury and
remain elevated at day 7 (Figure 2G). The percentage of
these OX-42+ macrophages that express NgR1 increases
from approximately 30% at day 3 to 75% at day 7 post-
lesion (Figure 2H). An increase in NgR1 mRNA is detected
in 3 and 7 day lesioned sciatic nerve (Figure 2I), providing
evidence that the NgR1 detected in macrophages is due
to de novo synthesis after injury. Furthermore, the NgR1
immunoreactivity in tissue sections appears to be present
around the periphery of these cells, especially by day 7
post-crush (Figures 2D–2F), suggesting a cell surface
localization.
To confirm that NgR1 is on the cell surface of the mac-
rophages, we dissociated macrophages from 3 and 7 day
post-crush rat sciatic nerves by mild trypsinization, plated
the cells onto poly-L-lysine (PLL) coated round glass cov-
erslips for 2 hr, and incubated the live cells with NgR1 an-
tibodies to detect cell surface labeling. These experiments
show punctate cell surface localization of NgR1 (Figures
3A–3F). The percentage of OX-42+ macrophages that ex-
press NgR1 on the cell surface almost doubles between
days 3 and 7 post-crush (Figure 3G), similar to that seen
in vivo, as noted above. Furthermore, NgR1 immunoreac-
tivity is detected in 70.6% ± 2.0% and 81.5% ± 10.5%
of very strongly OX-42-immunostained macrophages at
Neuron
NgR Mediates Macrophage Repulsion in Injured NerveFigure 2. Macrophages in the Degener-
ating Nerve Express NgR1
Double immunofluorescence labeling of injured
rat sciatic nerve at 5 days post-crush (A–C)
shows that OX-42+ macrophages (B) express
NgR1 (large arrows in [A]–[C]). OX-42+ macro-
phages that do not express NgR are also seen
(small arrow in [A]–[C]). Tissue section of a 7
day crush-injured nerve (D–F) shows that the
NgR1+ immunoreactivity (D) of OX-42+ macro-
phages (E) appears to be largely localized to
the cell surface of these large phagocytic cells
(arrowheads in [D]–[F]). Micrographs are of lon-
gitudinal frozen sections at 3mmdistal to the in-
jury site; (C) and (F) show triple labeling for
NgR1, OX-42, and DAPI. Scale bar, 50 mm.
Quantification of the number of OX-42+ macro-
phages (G), and thepercentageofOX-42+mac-
rophages that express NgR1 (H) in the distal
segment of 3, 5, and 7 day post-crush nerves
reveal an increase in macrophage number and
the proportion that express NgR1 between 3
and 7 days. Data represent mean ± SEM; *p <
0.001. n = 3 for each age group. (I) RT-PCR
analysis of NgR1 expression in sciatic nerve
shows increasing upregulation of NgR1 mRNA
in the distal nerve segment at 3 and 7 days after
crush injury. PPIA is used as a control (see Ex-
perimental Procedures for more details).3 and 7 days, respectively, indicating that NgR1 is mainly
expressed bymore activatedmacrophages (arrows in Fig-
ures 3A–3F), as increased expression of the aMb2 integrin
recognized by the OX-42 antibody is an indicator of
a greater activation state. Since macrophages in the le-
sioned nerve are largely derived from blood monocytesthat enter the nerve during the first week after injury (Bend-
szus and Stoll, 2003), we assessed the percentage of
blood monocytes that express NgR1. Only 17.2% ±
4.3% of the monocytes show NgR1 immunoreactivity on
the cell surface (Figure 3G). This includes cells that show
relatively low as well as higher levels of OX-42 staining,Figure 3. Cell Surface Expression of
NgR1 by Macrophages
Montages showing immunofluorescence label-
ing of live cultures of macrophages harvested
from 3 (A–C) and 7 day (D–F) crush-injured
nerves reveal that OX-42+ macrophages (A
and D) show punctate cell surface labeling for
NgR1 (B and E). Note that the more activated
macrophages (i.e., stronger OX-42 immunore-
activity) express more NgR1 (arrows). Scale
bar, 20 mm. (G) Only a small percentage of
OX-42+ blood monocytes express NgR1. The
percentage of OX-42+ macrophages in the le-
sioned nerves that show cell surface NgR1+ la-
beling increases significantly from monocytes
and between 3 and 7 days post-crush injury.
Data represent mean ± SEM; *p = 0.003, **p <
0.001. n = 3 for each group.Neuron 53, 649–662, March 1, 2007 ª2007 Elsevier Inc. 651
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NgR Mediates Macrophage Repulsion in Injured Nervesuggesting that the latter may be cells that were activated
by the purification process. Only 11.5% ± 3.1% of mono-
cytes that express low levels of OX-42 are NgR1+, indicat-
ing that only a small number of monocytes express NgR1
in the resting state. These data suggest that increasing
numbers of macrophages express NgR1 after they enter
the degenerating nerve and become activated, i.e., after
they phagocytose axonal and myelin debris. The delayed
expression of NgR1 in macrophages after they enter the
nerve also suggests that it is unlikely to have a role in
the recruitment of these cells into the damaged nerve.
We also assessed the cell surface expression of NgR2 in
cells dissociated from the lesioned nerves as described
above. NgR2 is expressed on the cell surface of
53.4% ± 1.8% of the macrophages from 3 day and
74.1% ± 1.9% of 7 day post-lesioned nerve (Figures 4A–
4C and 4J). As with NgR1, only 16.5% ± 3.3% of mono-
cytes purified from the blood were NgR2+, of which only
12.3% that were weakly OX-42+ express NgR2. Since
both NgR1 and NgR2 are GPI-anchored proteins, we ex-
amined whether their transmembrane binding partners,
p75NTR and TROY (a member of the TNF receptor family)
(Filbin, 2003; Park et al., 2005; Shao et al., 2005; Yama-
shita et al., 2002), are expressed by these macrophages.
p75NTR was not expressed by macrophages at any time
points (Figures 4D–4F); however, TROY was expressed
by 65.7% ± 4.7% and 69% ± 5% of OX-42+ macrophages
from 3 day and 7 day lesioned nerves, respectively (Fig-
ures 4G–4I and 4K). Although there was no significant dif-
ference in the numbers of cells expressing TROYat 3 and 7
days post-injury, only 20.8% of blood monocytes express
TROY (Figure 4K), of which only 15.8% that were weakly
OX-42+ express TROY. TROY, like NgR1 and NgR2, is
therefore expressed in monocytes/macrophages largely
after they enter the lesioned nerve and become activated.
NgR/Ligand Interactions Mediate Reduced Binding
and Repulsion of Macrophages to Myelin
Since NgR1 is known tomediate the inhibitory or repulsive
effects of several myelin proteins (Nogo-A, MAG, and
OMgp) to cause collapse of axonal growth cones and
NgR2 mediates MAG-induced neurite growth inhibition,
we first assessed whether macrophages that express
these receptors show repulsion to myelin, i.e., show re-
duced binding to amyelin substrate in vitro. Macrophages
were dissociated from the distal segment of 3 and 7 day
crushed nerves and plated onto myelin-coated tissue cul-
ture wells for 3 hr. The number of macrophages from 7 day
post-crush nerves that bind to the myelin substrate is re-
duced by 35% as compared to macrophages obtained
from 3 day crushed nerves (Figure 5A), which correlates
well with the increase in the percentage of macrophages
that express NgR1 and NgR2 at 7 days post-injury.
To obtain direct evidence for the role of NgRs in reduc-
ing the binding of 7 day post-injury macrophages to mye-
lin, we assessed the effect of selective gene silencing
(knockdown) of NgR1 and NgR2 by small interfering
RNA (siRNA). For these experiments, macrophages from652 Neuron 53, 649–662, March 1, 2007 ª2007 Elsevier Inc.7 day crushed sciatic nerves were harvested and trans-
fected in vitro with either a cocktail of NgR1 and NgR2
siRNA or negative control siRNA containing a nonspecific
sequence. Cells were first monitored daily by immunoflu-
orescence labeling, which showed a sustained knock-
down of NgR1 and NgR2 cell surface protein expression
for up to 4 days in culture (see Figures S1A and S1B in
the Supplemental Data available online). The greatest
knockdown efficiency was achieved 2 days after transfec-
tion, with a 69% reduction of NgR1+ cells and 72% reduc-
tion of NgR2+ cells. The percentage of NgR1+ and NgR2+
Figure 4. Cell Surface Expression of NgR2 and TROY by
Macrophages
Micrographs showing macrophages dissociated from the distal
stumps of 7 day crushed adult rat sciatic nerves. Macrophages were
identified by immunofluorescence staining with the OX-42 antibody.
(A), (D), and (G) show cell surface labeling for NgR2 (B), and TROY
(H) but not for p75NTR (E). Panels (C) and (I) are merged images of
panels (A) and (B) and (G) and (H), respectively, and panel (F) is amerge
of panels (D) and (E) plus the nuclear DAPI stain. Scale bar, 20 mm. (J)
Only 16.5%of OX-42+monocytes express NgR2 on the cell surface. In
contrast, about 53% of the macrophages from nerves 3 days after in-
jury express NgR2 (*p<0.001) and this number increases further to
about 74% at 7 days post-injury (**p = 0.002). (K) TROY is expressed
on the cell surface of about 20% of bloodmonocytes, and this number
increases rapidly to between 65% and 70% in macrophages obtained
from 3 and 7 day crushed nerves. The values at 3 and 7 days are sig-
nificantly higher than for blood monocytes (*p = 0.003). Data represent
mean ± SEM; n = 3 for each group.
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NgR Mediates Macrophage Repulsion in Injured NerveFigure 5. NgR/Ligand Interactions and
RhoA Activation Mediate Reduced Bind-
ing and Repulsion of Macrophages to
Myelin
(A) Graph showing the binding of macrophages
obtained from 3 and 7 day crush-injured nerves
plated on myelin. The binding of these cells is
significantly reduced at 7 days post-injury
(*p = 0.025).
(B) Slot blots show a reduction in NgR1 and
NgR2 protein expression in macrophages
from 7 day lesioned nerves, 2 days after trans-
fection with siRNA specific for NgR1 and NgR2
(+) as compared to macrophages treated with
nonspecific siRNA (). Quantification of the
slot blot data (graphs) indicates a knockdown
in NgR1 and NgR2 expression of approxi-
mately 70%, 2 days after transfection with spe-
cific siRNA (+, *p < 0.001).
(C) Graph of macrophage binding to myelin
substrate 2 days after transfection with specific
(+) or nonspecific () siRNA. Binding is signifi-
cantly increased after NgR1 and NgR2 siRNA
knockdown (+) (*p = 0.03). The values were nor-
malized to that obtained from poly-L-lysine
(PLL) coated areas of the same wells (see Ex-
perimental Procedures).
(D) Treatment with Y-27632 (10 mM) of macro-
phages harvested from nerves 3 and 7 days af-
ter injury increases binding of these cells tomy-
elin-coated substrates (*p = 0.03). Controls
were treated with vehicle.
(E) A similar reversal of the decrease in binding
to recombinant MAG-coated substrates is also
detected when cultures were treated with Y-
27632 (*p = 0.028).
(F and G) Micrographs showing cultures of the migration assay with macrophages from 3 and 7 day lesioned nerves. Note that the majority of 7 day
macrophages are repulsed at myelin interface ([G], arrows), while a greater number of 3 daymacrophagesmigrate across the myelin interface (F). The
dashed lines indicate the myelin interface. Scale bar, 200 mm.
(H) Quantification of the migration assay shows a marked reduction in migration of macrophages from 7 day lesioned nerves versus 3 day lesioned
nerves across the myelin interface (*p = 0.004).
(I) Quantification of the migration assay using macrophages from 7 day crushed nerves, 2 days after transfection with NgR1/NgR2-specific (+) or non-
specific control () siRNA. The inhibition of migration seen with cells treated with control siRNA () was completely reversed with cells after NgR1/
NgR2 siRNA knockdown (+) (*p < 0.001).
All data represent mean ± SEM; n = 3.macrophages transfected with negative control siRNA
was not significantly different from nontransfected macro-
phages over 4 days in culture (p = 0.959). The knockdown
at 2 days in the NgR-specific siRNA-treatedmacrophages
was further confirmed by slot blot analysis that showed
a 78% and 70% reduction in NgR1 and NgR2 protein ex-
pression, respectively, as compared to control siRNA-
treated cells (Figure 5B). We then assessed the ability of
macrophages from 7 day lesioned nerves, 2 days after
transfection with NgR1/NgR2 siRNA, to bind to myelin.
The assay used was similar to the assay described
above. The NgR1/NgR2 siRNA-transfected macrophages
showed a 55% increase in binding to the myelin-coated
substrate as compared to control siRNA-transfected
macrophages (Figure 5C). The binding tomyelin by control
(nonspecific) siRNA-transfected macrophages was simi-
lar to that observed with nontransfected macrophages
from 7 day lesioned nerves. These results therefore pro-vide direct evidence that NgR1 and NgR2 on macro-
phages mediate the reduced binding of these cells to
myelin.
NgR1, with its coreceptors, has been shown to mediate
growth cone collapse and axon growth inhibition via acti-
vation of RhoA and downstream molecules such as Rho-
associated kinase (ROK) (Filbin, 2003; Fournier et al.,
2003; McKerracher and David, 2004). We therefore exam-
ined whether RhoA plays a role in the reduction of macro-
phage binding tomyelin by treating dissociated cultures of
macrophages obtained from the distal segment of 3 and 7
day crushed nerves with Y-27632, an inhibitor of ROK.
Blocking ROK increased binding of macrophages from
3 and 7 day crushed nerves to myelin up to 100% and
81% of PLL-control values, respectively (Figure 5D).
These results suggest that the expression of NgR1 and
NgR2 by phagocytic macrophages reduces their binding
to myelin via a RhoA-dependent mechanism. To furtherNeuron 53, 649–662, March 1, 2007 ª2007 Elsevier Inc. 653
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NgR Mediates Macrophage Repulsion in Injured Nerveassess whether these effects are mediated via MAG, one
of the axon growth inhibitors found in myelin, we carried
out similar in vitro assays with recombinant MAG-coated
wells. MAG was chosen because (1) it is a ligand for
both NgR1 and NgR2; (2) NgR2 selectively binds only
MAG and not Nogo-A and OMgp; and (3) MAG is ex-
pressed in peripheral nerve myelin but Nogo-A is not.
We found that, like the effects of myelin substrates, the
binding of macrophages was also inhibited by recombi-
nant MAG-coated substrates, and this effect could also
be reversed by treatment with the ROK inhibitor Y-
27632. Blocking ROK increased binding of macrophages
obtained from 7 day lesioned nerves to MAG-coated sub-
strates up to 86%of the PLL-control value (Figure 5E). This
reduction in binding to myelin and MAG may reflect a re-
pulsive effect of myelin proteins onmacrophage behavior.
To further assess whether this is a repulsive interaction,
we designed a migration assay in which macrophages
from 3 and 7 day lesioned nerves were plated on the
poly-L-lysine-coated portion of the culture substrate and
allowed to migrate toward an adjacent myelin-coated re-
gion. The behavior of the cells after they contact themyelin
interface was assessed 24 hr after plating. Interestingly,
macrophages from the 3 day lesioned nerves migrated
across the interface on to the myelin substrate (Figure 5F).
In contrast, the majority of the macrophages from the 7
day lesioned nerves appeared to be arrested at the myelin
interface (Figure 5G). Quantification of the macrophages
that migrated on to myelin showed a 65% reduction be-
tween cells from 3 and 7 day lesioned nerves (Figure 5H).
To obtain direct evidence that this reduction in the migra-
tion of macrophages from 7 day lesioned nerves on to my-
elin ismediated byNgRs, we did themigration assay using
these cells after siRNA knockdown of NgR1 and NgR2.
Only 27% of the control siRNA-treated macrophages
from 7 day lesioned nerves migrated across the myelin
interface on to myelin. This inhibition was completely re-
versed in the NgR1/NgR2 siRNA-transfected macro-
phages, which showed migration of up to 100% of PLL-
control values (Figure 5I). Taken together, these results
indicate that NgR expressed on macrophages mediates
the repulsion of these cells by myelin.
Macrophage Efflux from the Lesioned Sciatic Nerve
Is Controlled by the Presence of Myelin around
Remyelinated Axons
We next assessed whether the reduced binding of macro-
phages to myelin and the repulsion of macrophages by
myelin in vitro is reflected in vivo by increased macro-
phage clearance from injured nerves in the presence of
myelin. To do this, we compared the number of macro-
phages in the adult rat sciatic nerve 14 days post-lesion
in two injury models: (1) sciatic nerve crush injury in which
axons regenerate into the distal nerve segment and be-
come remyelinated, and (2) sciatic nerve cut and ligation
in which axons are prevented from regenerating, and
thus the distal nerve segment lacks newly synthesized
myelin. The number of macrophages in the distal segment654 Neuron 53, 649–662, March 1, 2007 ª2007 Elsevier Inc.of the cut and crushed nerves 14 days after lesion, quan-
tified from longitudinal frozen sections labeled by immu-
nofluorescence for OX-42, show that there is a significant
increase in the number of macrophages in the cut/ligated
nerves (201.8 ± 14.8/0.25 mm2; p = 0.003) as compared to
the crushed nerves (132.1 ± 14.6/0.25 mm2). These data
suggest that in the absence of newly synthesized myelin
the clearance of macrophages from the injured nerve is
impaired.
Macrophages penetrate the Schwann cell basal lamina
to reach and phagocytose the myelin that is shed by
Schwann cells after nerve injury. In crush-injured nerves,
axons regenerate through Schwann cell basal lamina
tubes that contain macrophages. If macrophages that ex-
press NgR1 were repulsed by myelin, we would predict
that they would leave the Schwann cell basal lamina
tube when the newly regenerated axons become remyeli-
nated. On the other hand, in the cut/ligated nerves in
which axon regeneration is prevented, the macrophages
that have entered the Schwann cell basal lamina to phago-
cytose debris would not be signaled to leave because of
the lack of newly synthesized myelin. To assess whether
this is the case, we examined cross-sections of 14 day
cut/ligated or crush-injured nerves by electron micros-
copy. Quantification of cross-sections of the nerve by
electron microscopy revealed a 65% increase in the total
number of macrophages in the cut/ligated nerves as com-
pared to crush-injured nerves (Figure 6A). Furthermore,
the number ofmacrophages within the Schwann cell basal
lamina in the cut/ligated nerves is 5.8-fold greater than in
Figure 6. Macrophage Clearance from Lesioned Sciatic
Nerve Is Controlled by the Presence of Newly Synthesized
Myelin around Regenerated Axons
(A) Quantitative EM analysis of the number of macrophages in 14 day
injured nerves indicates that their number is significantly greater in cut/
ligated nerves than in crush-injured nerves (*p = 0.003).
(B) The percentage of macrophages located within the Schwann cell
basal lamina. Almost all the macrophages in cut/ligated nerves remain
inside the basal lamina (97.8%), while in crush-injured nerves that re-
generate and remyelinate, only 48.3% are within the Schwann cell
basal lamina, of which 29% are associated with axons that have not
yet become remyelinated, and the remaining 19% are in basal lamina
tubes that lack regenerated axons (*p = 0.001).
(C) The percentage of macrophages located outside the Schwann cell
basal lamina. About 52% of the macrophages in the regenerating
crush-injured nerves lie outside the Schwann cell basal lamina as com-
pared to only about 2% in the cut/ligated nerves (*p < 0.001).
All data represent mean ± SD; n = 3.
Neuron
NgR Mediates Macrophage Repulsion in Injured NerveFigure 7. Presence of Newly Synthesized
Myelin Influences the Efflux of Macro-
phages from the Schwann Cell Basal
Lamina
Electron micrographs taken from cross-
sections of the sciatic nerve, 2 mm distal to
the site of cut/ligation (A–C) and crush injury
(D–H) taken 14 days after lesioning.
(A and B) Macrophages containing clear and
light-density vacuoles that are end-state prod-
ucts of myelin degradation are located within
the Schwann cell basal lamina in the nonregen-
erating cut/ligated nerve. The ‘‘insert’’ in panel
(A) is a higher magnification of the boxed area
that illustrates the basal lamina (arrowheads)
surrounding the cell membrane.
(C) A motile macrophage that lacks phagocy-
tosed material or secondary lysosomes but
has numerous cytoplasmic processes (arrow-
heads) and is located outside of the basal lam-
ina suggests that it might be a newly recruited
cell.
(D) In contrast, after crush injury, numerous
axons (a) in various stages of remyelination
are visible in the nerve. In addition, many foamy
phagocytic macrophages (m) located outside
the Schwann cell basal lamina are seen close
to the blood vessel (bv). Note that none of the
myelinated axons have macrophages within
their basal lamina.
(E and F) Additional examples of macrophages
(m) with phagocytosed material and end-state
products of myelin-degradation. These macro-
phages are located outside the Schwann cell
basal lamina as evident by the absence of
basal lamina around them. The absence of the basal lamina is illustrated in the higher magnification shown in the ‘‘insert’’ (arrowheads) in panel
(F), which is taken from the boxed area. Note that the basal lamina sheaths of myelinated axons (‘‘a’’ in [E] and [F]) are devoid of macrophages.
(G) A macrophage (m) with an elongated cytoplasmic process (arrowheads) that suggests that this is a motile cell. It is located outside the Schwann
basal lamina in the endoneurial space. The Schwann cell basal laminae of the two myelinated axons (a) are devoid of macrophages. Arrow indicates
small, unmyelinated axons.
(H) An example of a macrophage (m) that lies within a basal lamina that contains an axon (a) which lacks myelin. The ‘‘insert’’ at the bottom is a higher
magnification of the boxed area that illustrates the basal lamina (arrowheads). Note the larger size of this axon (a) as compared to the typical unmy-
elinated axons (arrows in [G] and [H]), which indicates that it has not yet been remyelinated.
Scale bar in (A)–(C) and (E)–(H), 2 mm; (D), 10 mm; insert in (A), 1 mm; insert in (F) and (H), 0.5 mm.crushed/regenerated nerves. The cell counts for the two
groups are 118 ± 21.5 cells/4 3 105 mm2 in cut/ligated
nerves versus 19.3 ± 5.1 cells in crush-injured nerves in
the same area (p < 0.001). In the cut/ligated nerves, this
represents 97.8% ± 1.8% of the total number of macro-
phages in the distal nerve segment (Figure 6B). Examples
of macrophages within the Schwann cell basal lamina in
cut/ligated nerves are shown in Figures 7A and 7B. In con-
trast, of the small number of macrophages present in
crushed/regenerated nerves, only 48.3% ± 6.3% are
within Schwann cell basal lamina, of which 29% are asso-
ciated with nonmyelinated axons (Figure 6B). Based on
the size of these axons, they are likely to be axons that
have not yet become remyelinated (Figure 7H). The re-
mainder of the macrophages within the Schwann cell
basal lamina in the crushed/regenerated nerves are within
basal lamina tubes that lack regenerated axons (Fig-
ure 6B). Importantly, none of the large number of myelin-ated axons in the crushed/regenerated nerves contain
macrophages within their basal lamina (Figures 7D–7G),
including those that have just begun to myelinate
(Figure 7D and Figures S2A and S2B). Additionally,
51.7% ± 6.3% of the total number of macrophages in
crushed/regenerated nerves that contain newly synthe-
sized myelin lie in the endoneurial space outside the
Schwann cell basal lamina, as compared to only 2.2% ±
1.8% in the cut nerves lacking myelin (Figures 6C and
7D–7G). In the crushed nerves, macrophages located out-
side Schwann cell basal lamina were detected in close
proximity to blood vessels, suggesting that these cells
may be migrating toward these vessels (Figure 7D). Mac-
rophageswere easily identified by their foamy appearance
due to the presence of numerous light-density vacuoles
and lysosomes containing the end products of phagocy-
tosis, and when located outside the Schwann cell basal
lamina in crush-injured nerves, they possess an irregularNeuron 53, 649–662, March 1, 2007 ª2007 Elsevier Inc. 655
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cells (Figures 7E and 7G). Small-diameter, unmyelinated
axons ensheathed by Schwann cell were not associated
with macrophages (arrows in Figures 7G and 7H). This is
in keeping with previous studies showing that, following
injury, macrophages are not recruited into purely unmy-
elinated peripheral nerves to clear the minimal debris
that is present (Bray et al., 1972). Interestingly, macro-
phages lacking phagocytosed material and with morpho-
logical features of highly motile cells were also occasion-
ally detected in cut/ligated nerves, suggesting that they
continue to be recruited into nerves lacking myelin
(Figure 7C). The 14 day time point was chosen for these
studies because, at the earlier time point of 7 days, the
majority of the macrophages (71.6% ± 3.6%) in crush-
injured nerves were still contained within Schwann cell
basal lamina (Figure S2C). Furthermore, 96% of these
macrophages within the Schwann cell basal lamina were
associated with large nonmyelinated axons, indicating that
remyelination had not yet occurred. Only a small propor-
tion (13.6% ± 5.7%) of end-stage macrophages filled
with phagocytosed debris were found outside the basal
lamina.
Macrophage Efflux from Schwann Cell Basal Lamina
Is Impaired by Disrupting NgR/Ligand Interactions
We next carried out experiments to obtain direct evidence
whether NgR/ligand interactions influence macrophage
efflux out of the Schwann cell basal lamina after nerve-
crush injury by assessing this in two different strains of
gene knockout mice. Previous studies have reported
that NgR1 is a higher-affinity receptor for Nogo-A than
for MAG (Fournier and Strittmatter, 2001; Liu et al.,
2002), while NgR2 is a high-affinity receptor only for
MAG (Venkatesh et al., 2005). Since peripheral nerve my-
elin expresses high amounts of MAG but not Nogo-A, it
would have been preferable for us to use NgR2-deficient
mice. However, at present only NgR1-deficient mice are
available, which might be expected to yield only a moder-
ate effect on macrophage behavior after injury. On the
other hand,MAG-deficient mice provide the best opportu-
nity at present to disrupt the ligand/receptor interactions
of both NgR1 and NgR2, as peripheral myelin as men-
tioned above has MAG, the sole known ligand for NgR2,
but does not contain Nogo-A (GrandPre et al., 2000) and
has lower levels of OMgp (Huang et al., 2005). If our hy-
pothesis is correct, we would predict that macrophage ef-
flux from the Schwann cell basal laminawould be impaired
in the presence of newly synthesized myelin surrounding
the regenerated axons in NgR1- and MAG-deficient mice.
We therefore quantified by electron microscopy the
number of macrophages containing phagocytosed debris
that are found together with myelinated axons within the
same Schwann cell basal lamina tube. This analysis was
carried out on cross-sections of the nerve 14 days after
crush injury in NgR1-deficient (Zheng et al., 2005) and
MAG-deficient mice (Li et al., 1994) and their respective
wild-type controls. Interestingly, in NgR1-deficient mice,656 Neuron 53, 649–662, March 1, 2007 ª2007 Elsevier Inc.16% of the macrophages contained within the Schwann
cell basal lamina were associated with well myelinated
axons (Table 1). Their containment within the same basal
lamina and association with myelinated axons are clearly
visible by electron microscopy (Figures 8A and 8B). In
contrast, in crush-injured wild-type mice, no macro-
phages were present within the Schwann cell basal lamina
that contained myelinated axons (Table 1). The partial
effect seen in the NgR1-deficient mice is not surprising
given the lower affinity of NgR1 for MAG (Liu et al., 2002;
Venkatesh et al., 2005). As predicted, in MAG-deficient
mice, double the numbers of macrophages (30%, p =
0.01) in the basal lamina were associated with myelinated
axons as compared to NgR1 null mice (Table 1 and
Figure 8C and 8D). Importantly, this was never observed
in the wild-type mice 14 days after crush injury (Table 1).
It is possible that OMgp, which is localized to the region
of the paranodal loops in peripheral nerve myelin (Huang
et al., 2005), may also exert some effect on macrophage
responses in the MAG null mice. These data, however,
provide strong evidence that interactions between NgRs
and their ligands may provide one of the initial signals
for macrophage repulsion by newly synthesized myelin,
resulting in the efflux of these cells from the Schwann
cell basal lamina.
As NgR/ligand interactions in neurons have been shown
to be mediated by Rho activation, and as our in vitro stud-
ies detailed above also indicate that macrophage re-
sponses to myelin are mediated via Rho activation, we
next assessed the effects of treating crush-injured rat sci-
atic nerve with the ROK inhibitor Y-27632. By blocking
Rho activation in these nerves,36%of themacrophages
remaining inside the Schwann cell basal lamina were
associatedwithwell myelinated axons at 14 days after sci-
atic nerve crush injury in rats (Table 1 and Figures 8E and
8F). Macrophages associated withmyelinated axonswere
not present in vehicle-treated control injured nerves (Table
1). Taken together, these results further suggest that NgR/
ligand interactions via Rho-A-mediated signaling is likely
Table 1. Disruption of NgR/Ligand Interactions Impairs
Macrophage Efflux from Schwann Cell Basal Lamina
Null/Treated (%) Wild-Type/Vehicle (%)
NgR1 16.3 ± 1.1 0
MAG 29.1 ± 5.1 0
Y-27632 36.3 ± 7.1 0
The percentage of macrophages located within the Schwann
cell basal lamina that also contained well myelinated axons,
14 days after sciatic nerve crush injury in NgR1 null and
MAG null mice, and rat sciatic nerves treated with Y-27632
compound, and their respective controls. The mean values
for the MAG null and the Y-27632 groups are significantly dif-
ferent from the NgR1 null mice (p = 0.01 and 0.02, respec-
tively). The MAG null and the Y-27632 groups are not signifi-
cantly different from each other. Data represent mean ± SD;
n = 3.
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teractions Impairs Macrophage Efflux
from Schwann Cell Basal Lamina in the
Presence of Myelinated Axons
Electron micrographs taken from cross-sec-
tions of 14 day crushed sciatic nerve, 2mmdis-
tal to injury from NgR1-deficient (A and B) and
MAG-deficient (C and D) mice and Y-27632-
treated rats (E and F). Note the presence of
macrophages (m) laden with phagocytosed
myelin debris that are contained alongwith fully
myelinated axons (a) within the same Schwann
cell basal lamina. The ‘‘inserts’’ in each panel
are higher magnification of boxed areas that
show where the basal lamina (arrowheads) is
continuous around the macrophage and myeli-
nating Schwann cell. Panel (D) shows a region
of the paranodal loop of myelin that is less
compact than the myelin sheaths in the other
examples. Panels (E) and (F) illustrate exam-
ples of Y-27632-treated rats showing end-
stage phagocytic macrophages (m) with clear
vacuoles of myelin breakdown products lo-
cated in the same Schwann cell basal lamina
as the myelinated axons (a). The macrophage
(m) in (F) is extremely large, and the electronmi-
crograph shows only a portion of the cell.
Scale bars in (A)–(E), 2 mm; (F), 1 mm. Higher
magnification ‘‘inserts’’ in (A) and (E), 1 mm,
(B)–(D) and (F), 0.5 mm.to initiate the repulsion of macrophages by newly syn-
thesized myelin and their subsequent efflux from the
Schwann cell basal lamina into the endoneurial space.
This being one of the first steps in the clearance of macro-
phages from injured nerves and the termination of inflam-
matory responses at the end of the period of Wallerian
degeneration.
DISCUSSION
The clearance of immune cells from the site of inflamma-
tion that ultimately results in the termination of the inflam-
matory response is essential for affected tissues to return
to their normal basal state. If immune cells, such as mac-
rophages, persist for long periods beyond the time re-
quired for tissue repair, these cells may contribute to tis-
sue damage through the release of toxic mediators
(Kiefer et al., 2001; Prineas and McLeod, 1976). In injured
peripheral nerves, the entry of macrophages of hematog-
enous origin and their activation leading to phagocytosis
of debris, followed by their clearance from the nerve, is
precisely timed (Bruck, 1997; Leskovar et al., 2000; Muel-
ler et al., 2003). This well-coordinated sequence of macro-
phage responses serves to rid the distal nerve segment ofits myelin and axonal debris and prepare the distal seg-
ment to receive regenerating axon sprouts. Much of the
work in the field has focused on the mechanisms that un-
derlie macrophage recruitment and activation (De et al.,
2003; Kuhlmann and Bruck, 1999; Rotshenker, 2001,
2003; Rotshenker et al., 1992; Saada et al., 1996; Sha-
mash et al., 2002; Siebert and Bruck, 2003; Siebert
et al., 2001, 2000; Stoll et al., 1993). The termination of
this macrophage response is thought to involve, in part,
the downregulation of proinflammatory cytokines and
the upregulation of anti-inflammatory ones (George
et al., 2004; Perrin et al., 2005; Rotshenker, 2001; Sha-
mash et al., 2002; Stoll et al., 2004). Previous studies
have reported that only a small number of macrophages
(2%–4%) show signs of apoptosis at day 10 post-injury
(Kuhlmann et al., 2001), while other studies failed to detect
apoptotic macrophages after sciatic nerve crush injury
(Mueller et al., 2003). The majority of the macrophages
are thought to leave the nerve via the circulation into the
regional lymph nodes and spleen (Kuhlmann et al.,
2001). Interestingly, we observed examples by electron
microscopy in which macrophages located outside the
Schwann cell basal lamina appear to migrate toward
blood vessels.Neuron 53, 649–662, March 1, 2007 ª2007 Elsevier Inc. 657
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jury, they need to penetrate into the Schwann cell basal
lamina tube to be able to phagocytose the myelin that is
shed by Schwann cells. Therefore, before macrophages
can migrate out of the lesioned nerve after phagocytosis
is completed, they will first need to migrate out of the
Schwann cell basal lamina into the endoneurial space.
Our work suggests that this initial step is mediated via re-
pulsive interactions between NgRs expressed by macro-
phages and NgR ligands such as MAG present in newly
forming myelin around regenerated axons. NgR1 and
NgR2 are known to mediate inhibitory signaling that
causes collapse of axonal growth cones (Domeniconi
et al., 2002; Filbin, 2003; Fournier et al., 2001; Venkatesh
et al., 2005). NgR1 is also expressed by glioma cells and
mediates reduced adhesion and migration of these cells
in response to MAG (Liao et al., 2004). We show here
that the majority of highly activated phagocytic macro-
phages from the 7 day crush-injured nerve express
NgR1 and NgR2 and exhibit reduced binding to myelin
and recombinant MAG in vitro, which can be neutralized
by siRNA knockdown of NgR1 and NgR2. Additionally,
our in vitro migration assay also indicates that macro-
phages from 7 day lesioned nerves are repulsed by myelin
via interactions with NgR. The NgR ligand MAG is rapidly
re-expressed in remyelinating peripheral nerve after crush
injury (LeBlanc and Poduslo, 1990) and is therefore avail-
able to interact with NgR1 andNgR2 expressed onmacro-
phages located within the Schwann cell basal lamina. This
repulsive interaction between NgRs expressed on macro-
phages and the NgR ligands expressed on Schwann cell
membranes occurs as the Schwann cells begin to remye-
linate because axons with even the first few turns ofmyelin
are devoid of macrophages within their basal lamina (Fig-
ures S2A and S2B). This inhibitory effect may reflect a re-
pulsive interaction with myelin as has been reported for
neurons and glioma cells. As with neurons (Filbin, 2003;
McKerracher and David, 2004), this macrophage effect
could also be neutralized by inactivating ROK, a down-
stream target of RhoA. NgR1 is a GPI-anchored protein
that has been reported to act via its transmembrane core-
ceptors, p75NTR (Filbin, 2003; Yamashita et al., 2002) or
TROY (Park et al., 2005; Shao et al., 2005), to activate
RhoA (Fournier et al., 2003; Winton et al., 2002; Yamashita
et al., 2002, 1999). Our data indicate that none of the mac-
rophages express p75NTR but about 65%–70% of macro-
phages in the lesioned sciatic nerve express TROY at 3
and 7 days after nerve injury. It is possible that a receptor
complex of TROY with NgR1 and NgR2 may mediate the
macrophage efflux response after nerve injury, although
the coreceptors for NgR2 have yet to be identified. Rho ac-
tivation reduces adhesion and increases migration of
monocytes, and these responses can be reversed by in-
hibiting RhoA with C3 transferase (Aepfelbacher et al.,
1996; Pomorski et al., 2004). Interaction of NgR onmacro-
phages with its ligands in newly synthesizedmyelin, there-
fore, has the potential to mediate repulsive effects in vivo
and convert them from adherent cells to motile ones that658 Neuron 53, 649–662, March 1, 2007 ª2007 Elsevier Inc.are stimulated to migrate out of the basal lamina. In the
nerve, the activation of RhoA is likely to occur on the
side of the macrophage that is in contact with newly syn-
thesizedmyelin and thus constitutes the retracting portion
of the cell, while the migrating front would be located on
the opposite side that is associated with the Schwann
cell basal lamina. RhoA activation in Schwann cells re-
duces their migration and promotes normal myelination
(Melendez-Vasquez et al., 2004; Yamauchi et al., 2004),
mediated by neurotrophins acting via p75NTR (Yamauchi
et al., 2004). RhoA activation can therefore affect multiple
cell types and influence different aspects of the response
of the nerve to injury, including macrophage efflux, axon
regeneration, and remyelination.
We provide strong in vivo evidence that the presence of
myelin stimulates macrophage efflux from the Schwann
cell basal lamina and thus influences their eventual clear-
ance from the lesioned sciatic nerve. In themodel in which
the sciatic nerve was cut and ligated to prevent axon re-
generation and therefore lacks newly synthesized myelin
in the distal nerve segment, almost 98% of the macro-
phages were still within the Schwann cell basal lamina
into which they had migrated to phagocytose the myelin
debris. In contrast, in crush-injured nerves in which axons
are permitted to regenerate and remyelinate, macro-
phages were not found in the Schwann cell basal lamina
of any of the remyelinated axons, including those in the
early stages of remyelination. Another noteworthy finding
is that the efflux of macrophages out of the Schwann cell
basal lamina results in a greater number of them leaving
the nerve, as the crushed nerves had 65% fewer macro-
phages than cut nerves as estimated by electron micros-
copy. This suggests that the efflux of macrophages out of
the Schwann cell basal lamina is a first step in their clear-
ance from the regenerating nerve. Once macrophages
have effluxed out of the Schwann cell basal lamina into
the endoneurial space, they will not be in direct contact
with myelin and thus not be influenced by it. Other factors
then play a role in their eventual clearance from the endo-
neurial space.
Additionally, unlike wild-type mice, macrophage efflux
from theSchwann cell basal lamina containingwellmyelin-
ated axons is impaired in NgR1-deficient mice and MAG-
deficient mice 14 days after crush injury. These data
provide direct evidence that interaction between NgR on
macrophages and their ligands such as MAG in Schwann
cell membranes that are beginning to form myelin around
regenerated axons signal macrophages to leave the
Schwann cell basal lamina. Furthermore, the effect of the
ROK inhibitor in vivo indicates that these NgR/ligand inter-
actions mediating macrophage responses in lesioned pe-
ripheral nerve may occur via Rho activation. These results
provide in vivo evidence that NgR-mediated interactions
with their ligands at the very early stages of myelination
contribute to the efflux of macrophages from Schwann
cell basal lamina. Interestingly, activatedmicroglia/macro-
phages in cerebral ischemic lesions and multiple sclerosis
lesions also express NgR1 (Satoh et al., 2005), as do
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shown). Our discovery of this novel (to our knowledge)
role for NgRs in mediating the efflux of macrophages
from inflamed neural tissue via interactions with myelin
could therefore have broader implications for the regula-
tion of inflammatory responses not only in other peripheral
nerve pathologies but also in CNS inflammation such as in
spinal cord injuries, stroke, and multiple sclerosis.
EXPERIMENTAL PROCEDURES
Sciatic Nerve Lesions
Adult female Sprague-Dawley rats (180–200 g, Charles River Labora-
tories) and adult MAG null (Mag < tm1Rod > /J) (Li et al., 1994), and
wild-type mice (6–8 weeks of age, obtained from Jackson Laborato-
ries) were deeply anesthetized with ketamine:xylazine:acepromazine
(50/5/1 mg/kg). Adult NgR null and wild-type mice on a (C57BL/
6x129S7) N2 background (Zheng et al., 2005) were deeply anesthe-
tized with Avertin (15 ml of 2.5% solution/g). A unilateral sciatic nerve
crush was performed in the region of the upper thigh using a laminec-
tomy forceps chilled in liquid nitrogen and held for 30 s. In other ani-
mals, the sciatic nerve was ligated at the same region and cut with
a pair of microscissors. This ligation prevented growth of axons into
the distal nerve segment. All procedures were approved by the McGill
University Animal Care Committee and followed the guidelines of the
Canadian Council on Animal Care or were approved by the Genentech
and Stanford Animal Care Committees.
Animals were euthanized by perfusion under deep anesthesia at
post-surgical survival times of 3, 5, 7, or 14 days with 0.1 M phosphate
buffer, followed by 4% paraformaldehyde in 0.1 M phosphate buffer.
The distal segment of the lesioned sciatic nerves and uninjured control
sciatic nerves were collected and longitudinal cryostat sections
(14 mm) picked up on gelatin-coated glass slides.
Immunofluorescence
Double or single immunofluorescence labelingof the sciatic nerveswas
carried out using standard protocols (De et al., 2003). The following pri-
mary antibodies were used: mouse monoclonal antibody SMI-312 for
neurofilaments (Sternberger Monoclonals; 1:5000); rabbit polyclonal
anti-NgR1 (1:100; Alpha Diagnostic International [ADI]); mouse mono-
clonal antibody OX-42 to detect macrophages (Serotec, 1:100). Pri-
marymonoclonal and polyclonal antibodies were detected with rhoda-
mine-conjugated rabbit anti-mouse IgG and fluorescein-conjugated
goat anti-rabbit IgG (Jackson Laboratories, 1:200), respectively. NgR
antibody specificity was assessed by immunofluorescence staining
of tissue sections from NgR1-deficient mice and Western blotting
(Figure S3). The specificity of the NgR1 antibody was determined by
the lack of immunofluorescence staining of tissue sections of sciatic
nerve from NgR1-deficient mice (Figures S3A–S3C) as compared to
wild-type nerve (Figures S3D–S3F). The tissue sections from NgR1-
deficientmice,however, stainedwith theNgR2antibody (datanotshown),
indicating that the NgR2 antibody does not cross-react with NgR1.
For quantification of macrophage numbers, digital images of longi-
tudinal sections of the sciatic nerve for each fluorophore (fluorescein,
rhodamine, and DAPI) were captured at a magnification of 203 using
a Retiga digital camera with Qcapture software. Images were taken at
1–3 mm distal to the injury site. A minimum of three sections from each
animal (n = 3 for each group) was analyzed to obtain the means. The
data are presented as the mean ± standard error of the mean (SEM).
Statistical significance was determined using the two-tailed student’s
t test. The alpha value was set to p < 0.05.
Cell Culture Studies
Adult rat sciatic nerve segments distal to the site of crush or cut injury
were obtained 3 and 7 days after lesion, cut into small pieces, and dis-sociated by incubation with 0.125% trypsin for 20 min. For immunoflu-
orescence staining, cells were plated on poly-L-lysine-coated 13 mm
round glass coverslips at a density of 1 3 105 and allowed to adhere
for 2 hr. To demonstrate cell surface localization of NgR1 and -2,
TROY and p75NTR live cells were incubated for 30min at room temper-
aturewith amousemonoclonal antibodyOX-42 (to labelmacrophages;
1:100, Serotec) and one of either polyclonal goat anti-NgR1 antibody
(1:100; R & D Systems) or rabbit anti-NgR1 (1:100; ADI), goat anti-
NgR2 (1:100; R & D Systems), or rabbit anti-NgR2 (1:100, ADI), goat
anti-TROY (1:100 R & D Systems) or p75NTR (1:100, provided by
Dr Phil Barker [McGill University]) in Hanks balanced salt solution
(HBSS), followed by a 30 min incubation with a goat anti-rabbit or don-
key anti-goat secondary antibody conjugated to fluorescein, andagoat
or rabbit anti-mouse secondary antibody conjugated to rhodamine
(1:200, JacksonLaboratories). Cellswere thenfixed in acetic acid:etha-
nol (1:9) for 20 min at 20C. Coverslips were then mounted on glass
slides in an aqueous nonfademountingmedium containing the nuclear
marker DAPI (Vector Laboratories). Themajority of the cells that are ob-
tained under these conditions are macrophages. A minimum of three
coverslips was prepared for each time point and the experiments re-
peated three times. Cellswere examinedwith aZeiss Axioskop fluores-
cencemicroscope, and at least 100OX-42+ cellswere countedoneach
coverslip, and the proportion that wasNgR1, NgR2, p75NTR, and TROY
positive recorded. Data are presented as a mean ± SEM.
For the cell adhesion assay, dissociated cells were plated in 96-well
plates coated with CNSmyelin or recombinant MAG as described pre-
viously (Huang et al., 1999). Briefly, the wells were coatedwith nitrocel-
lulose solubilized in ethanol. After drying the wells, they were coated
with poly-L-lysine (5 mg/ml) overnight. 0.4 mg of bovine myelin or re-
combinant MAG in a 2 ml drop in HBSS was placed in the center of
the wells and incubated for 3 hr at 37C. Myelin and recombinant
MAG were purified as previously reported (McKerracher et al., 1994).
The myelin or recombinant MAG drop was then removed, the dissoci-
ated cells plated in the wells at a density of 13 105 cells per well, and
placed in a tissue culture incubator at 37C and 5% CO2 for 2 hr. The
wells were washed with HBSS to remove unattached cells and then
fixed with 4% paraformaldehyde. Macrophages were easily identified
by their large size. The number of these large round cells was counted
in an area of 0.25 mm2. Additional experiments were performed by in-
cubating the macrophage cultures plated on myelin or MAG with the
ROK inhibitor (Y-27632, 10 mM; CalBioChem) or vehicle (PBS) for
30 min during the preplating stage and for the entire culture period of
3 hr. A minimum of four wells were plated with cells for each experi-
mental condition (myelin substrate, myelin with Y-27632, myelin with
PBS, MAG with Y-27632, MAG with PBS). Experiments were repeated
three times (n = 3). The number of macrophages bound to the various
substrateswas counted using an ocular grid in four consistent places in
each well within an area of 0.25 mm2. In addition, the number of mac-
rophages bound to the poly-L-lysine substrate around the edge of
the central myelin- or MAG-coated region within the same well was
also counted as an internal control. Data are presented as a mean ±
SEM. Statistical analysis was performed as described above.
Separation of Blood Monocytes
Blood monocytes were obtained by Percoll density centrifugation.
Cells were plated on poly-L-lysine-coated 13 mm round glass cover-
slips at a density of 2.53 105 cells and allowed to adhere for 3 hr. Cells
were then labeled by double immunofluorescence with the mouse
monoclonal antibody OX-42 and rabbit polyclonal anti-NgR1, NgR2,
p75NTR, and TROY as described above. Counts were made from three
coverslips prepared from each of three animals (n = 3), and the propor-
tions of NgR1, NgR2, p75NTR, and TROY positive monocytes were cal-
culated. Data are presented as mean ± SEM.
siRNA Knockdown of NgR1 and NgR2
The following siRNA sequences for rat NgR1 and NgR2 were designed
according to criteria stipulated by Elbashir et al. (2001). NgR1,Neuron 53, 649–662, March 1, 2007 ª2007 Elsevier Inc. 659
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CACCT-30. Oligonucleotide sequences were synthesized by Ambion.
Macrophages plated at a density of 1 3 106 in 24-well tissue culture
plates were incubated with 10 nM of fluorocein (FAM) labeled NgR1
and NgR2 siRNA or FAM-labeled negative control siRNA (nonspecific
Silencer negative control #1, Ambion) in OPTI-MEM medium contain-
ing 2 ml of Lipofectamine 2000 (Invitrogen) transfection agent. Cells
were incubated for 24 hr, after which the transfection medium was re-
placed by DMEM culture medium containing 10% fetal bovine serum
and the mitotic inhibitor cytosine arabinoside to prevent proliferation
of any fibroblasts, and cultured for up to 4 days. siRNA knockdown
was first assessed by slot blot analysis (see below) and immunofluo-
rescence staining for cell surface NgR1 and NgR2 on OX42-positive
macrophages at 1, 2, and 4 days after transfection. The 2 day time
point was used for the myelin-binding and migration assays. Experi-
ments were repeated three times (n = 3).
Slot Blots
Slot blots were used to detect the level of NgR1 and NgR2 protein in
macrophages purified from 7 day lesioned nerves, 2 days after trans-
fection with siRNA specific for NgR1 and NgR2 or negative control
siRNA. 10 mg of cell extract was blotted onto Protan Pure nitrocellulose
membrane (Schleicher and Schueil). Membranes were incubated with
goat anti-NgR1 and NgR2 antibodies (R & D systems; 1:2500, 1:2000,
respectively) overnight at 4C. After washing, the membranes were in-
cubated with donkey anti-goat secondary antibody conjugated to
horseradish peroxidase (HRP, 1:400,000) for 1 hr at RT, and visualized
using enhanced chemiluminescence (Perkin-Elmer Life Science,
Boston, MA). Densitometry was done using ImageQuant (Amersham
Biosciences, Piscataway, NJ).
Macrophage Migration Assay
Macrophages from 3 day and 7 day crushed rat sciatic nerves were
dissociated as described above and were purified on a Percoll gradi-
ent. The macrophages were further purified by immunopanning for
30 min in Petri dishes coated with anti-OX-42 antibodies (1:500, Sero-
tec). 24-well tissue culture plates were coated with poly-L-lysine, and
one side of each well was coated with myelin (10 ml of 0.2 mg/ml). Mac-
rophages were plated at a density of 1 3 105 in a 50 ml droplet on the
side coated only with poly-L-lysine and allowed to adhere for 4 hr be-
fore adding culture medium to the well. After 24 hr, the cultures were
fixed with 4% paraformaldehyde. To visualize the macrophages for
analysis, cellswere stainedwith anti-OX-42 antibody and abiotinylated
horse anti-mouse secondary antibody conjugated to HRP (1:200,
Jackson Laboratories). Immunoreactivity was visualized with diamino-
benzidine. The number of macrophages that had migrated past the
poly-L-lysine/myelin interface was quantified. Three to four wells per
group were quantified per experiment, and the experiments were re-
peated three times (n = 3).
In additional experiments, the migration assay was carried out with
macrophages from 7 day crushed rat sciatic nerves, 2 days after trans-
fection with NgR1 and NgR2 siRNA or nonspecific negative control
siRNA. The dissociation method used and the siRNA transfection pro-
tocol was similar to that described above. The number of macro-
phages that migrated past the poly-L-lysine/myelin interface was
quantified. Three wells were quantified per experiment and the exper-
iments repeated three times (n = 3).
Histochemical Staining
Luxol fast blue staining for myelin was done as follows: sections were
washed in PBS, dehydrated in increasing concentrations of ethanol
(50%–95%), and incubated in 0.1% Luxol fast blue (diluted in 95%eth-
anol and 10%acetic acid) overnight at 37C. Sections were then differ-
entiated in 0.05% lithium carbonate and 70% ethanol. Luxol fast blue
staining was combined with immunofluorescence and the sections
mounted in aqueous nonfade mounting medium containing the nu-
clear marker DAPI (Vector Laboratories).660 Neuron 53, 649–662, March 1, 2007 ª2007 Elsevier Inc.Electron Microscopy
Rat sciatic nerve injury groups included 7 day crush, 14 day crush and
cut, 14 day crush treated with Y-27632 or vehicle treatment. Mouse
sciatic nerve injury groups included 14 day crush MAG null and wild-
type, 14 day crush NgR1 null and wild-type mice. Y-27632 mixed in
a thrombin/fibrin gel (Tisseel; Baxter) at a concentration of 1 mM
Y-27632 (CalBioChem) was placed directly on the nerve over the
crush-injury site. In addition, daily injections of Y27632 (75 ml of
1 mM in 300 ml of PBS) were administered intraperitoneally. Rats in
the control group were treated with the vehicle.
Rats and mice were deeply anesthetized 7 or 14 days after sciatic
nerve injury and perfused with 0.1 M phosphate buffer followed by
3% glutaraldehyde, 0.5% paraformaldehyde in 0.1 M phosphate
buffer. The distal segment of sciatic nerve was post-fixed in 2% os-
mium tetroxide for 2 hr and processed for embedding in Epon. Thin
cross-sections of the nerves (n = 3 for each group) at a 2 mm distance
from the lesion site were stained with lead citrate and viewed with a
Philips CM 10 electron microscope. Macrophages were counted in
an area of 4 3 105 mm2, and their position within or outside the
Schwann cell basal lamina were recorded. Data are presented as the
mean ± SD. Statistical analysis was performed as described above.
RT-PCR
RNA was isolated from adult rat sciatic nerves using the RNeasy Lipid
TissueMinikit (QIAGEN) and reverse transcribed to cDNAwith the Om-
niscript Reverse Transcriptase Kit (QIAGEN). RT-PCR was performed
using the HotStarTaq PCRKit (QIAGEN). Primers usedwere as follows:
NgR1, F-50 AATGAGCCCAAGGTCACAACAAGC-30, R-50GTTGCCAT
GCAGAAAGAGATGCGT-30; Peptidylprolyl Isomerase A (PPIA), F-
50ATTCCAGGATTCATGTGCCAGGT-30, R-50-CAAAGACCACATGCT
TGCCATCCA-30. PCR was performed as described previously (Jeong
and David, 2003) with annealing temperatures of 61C for 30 cycles
(NgR1) and 62.5C for 23 cycles (PPIA). PPIA, also known as cyclophi-
lin A, was used as the internal control, since it shows less variability in
expression than GAPDH in inflamed tissue (Feroze-Merzoug et al.,
2002).
Supplemental Data
The Supplemental Data for this article can be found online at http://
www.neuron.org/cgi/content/full/53/5/649/DC1/.
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